BioLineRx Ltd.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2024 · Filed Mar 31, 2025
Contents
ITEM 16B. CODE OF ETHICS
. CODE OF ETHICS
In July 2011, our board of directors adopted a Code of Business Conduct and Ethics, or the Code of Conduct, that applies to all our employees, including without limitation our CEO, CFO and controller. Our Code of Conduct may be viewed on our website atwww.biolinerx.com. The information contained on or through our website, or any other website referred to herein, is not incorporated by reference into this Annual Report on Form 20-F. A copy of our Code of Conduct may be obtained, without charge, upon a written request addressed to our investor relations department, 2 HaMa’ayan Street, Modi’in 7177871, Israel (Telephone no. +972-8-642-9100) (e-mail: info@BioLineRx.com).
ITEM 16C
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.